Events
Events
Upcoming Events
Upcoming Events | |
---|---|
More events are coming soon. |
Archived Events
Archived Events | |
---|---|
Dec 03, 2024 at 10:00 AM EST
|
7th Annual Evercore HealthCONx Conference
|
Nov 04, 2024 at 8:30 AM EST
|
TG Therapeutics Q3 2024 Financial Results and Business Update
|
Aug 06, 2024 at 8:30 AM EDT
|
TG Therapeutics Q2 2024 Financial Results and Business Update
|
Jun 11, 2024 at 1:20 PM EDT
|
Goldman Sachs 45th Annual Global Healthcare Conference
|
Jun 05, 2024 at 1:30 PM EDT
|
Jefferies Global Healthcare Conference 2024
|
May 01, 2024 at 8:30 AM EDT
|
TG Therapeutics Q1 2024 Financial Results and Business Update
|
Feb 28, 2024 at 8:30 AM EST
|
Q4 and Year-End 2023 Financial Results and Business Update
|
Jan 09, 2024 at 4:30 PM PST
|
42nd Annual J.P.Morgan Healthcare Conference
View Presentation 3.2 MB
|
Nov 29, 2023 at 2:10 PM EST
|
6th Annual Evercore ISI HealthCONx Conference
|
Nov 06, 2023 at 3:10 PM EST
|
5th Annual Guggenheim Inflammation, Neurology & Immunology (INI) Conference
|
Nov 01, 2023 at 8:30 AM EDT
|
TG Therapeutics Q3 2023 Financial Results and Business Update
|
Sep 26, 2023 at 12:25 PM EDT
|
Cantor Global Healthcare Conference 2023
|
Sep 11, 2023 at 10:30 AM EDT
|
H.C. Wainwright 25th Annual Global Investment Conference
|
Aug 01, 2023 at 8:30 AM EDT
|
TG Therapeutics Q2 2023 Financial Results and Business Update
|
Jun 07, 2023 at 11:30 AM EDT
|
Jefferies 2023 Healthcare Conference
|
May 09, 2023 at 3:00 PM PDT
|
Bank of America Securities Health Care Conference 2023
|
May 01, 2023 at 8:30 AM EDT
|
TG Therapeutics Q1 2023 Financial Results and Business Update
|
Feb 28, 2023 at 8:30 AM EST
|
TG Therapeutics Q4 and Year-End 2022 Financial Results and Business Update
|
Jan 09, 2023 at 9:45 AM PST / 12:45 PM EST
|
41st Annual J.P. Morgan Healthcare Conference
|
Dec 29, 2022 at 8:30 AM EST
|
TG Therapeutics BRIUMVI™ (ublituximab-xiiy) FDA Approval Call
Dial in: 1-877-407-8029 (US) 1-201-689-8029 (Ex-US)
|
Nov 10, 2022 at 8:30 AM EST
|
TG Therapeutics Q3 2022 Financial Results and Business Update
|
Sep 12, 2022 at 7:00 AM EDT
|
H.C. Wainwright 24th Annual Global Investment Conference
|
Aug 08, 2022 at 8:30 AM EDT
|
TG Therapeutics Q2 2022 Financial Results and Business Update
|
May 24, 2022 at 7:00 AM EDT
|
H.C. Wainwright Global Investment Conference 2022
|
Apr 28, 2022 at 12:30 PM EDT
|
B. Riley Securities’ 2022 Virtual Neuro & Ophthalmology Conference
|
Apr 18, 2022 at 8:30 AM EDT
|
TG Regulatory Update Call
|
Mar 01, 2022 at 8:30 AM EST
|
TG Therapeutics Q4 and Year-End 2021 Financial Results and Business Update
|
Jan 27, 2022 at 10:00 AM EST
|
B. Riley Securities’ 2022 Oncology Conference
|
Jan 10, 2022 at 9:45 AM EST
|
40th Annual J.P. Morgan Healthcare Conference
View Presentation 3.2 MB
|
Nov 30, 2021 at 8:30 AM EST
|
TG Therapeutics Regulatory Update Call
|
Nov 18, 2021 at 3:00 AM EST
|
Jefferies Virtual London Healthcare Conference
|
Nov 11, 2021 at 12:00 PM EST
|
B. Riley Securities’ Fall 2021 Growth BioTech Best Ideas Virtual Conference
|
Nov 04, 2021 at 8:30 AM EDT
|
TG Therapeutics Q3 2021 Earnings Call and Business Update
|
Oct 14, 2021 at 12:30 PM EDT
|
TG ECTRIMS Investor & Analyst Event
|
Sep 27, 2021 at 10:40 AM EDT
|
2021 Cantor Virtual Global Healthcare Conference
|
Sep 20, 2021 at 8:30 AM EDT
|
TG iwCLL Investor & Analyst Event
|
Sep 13, 2021 at 7:00 AM EDT
|
H.C. Wainwright 23rd Annual Global Investment Conference
|
Aug 02, 2021 at 8:30 AM EDT
|
TG Therapeutics Q2 2021 Earnings Call and Business Update
In order to participate in the conference call, please call 1-877-407-8029 (U.S.), 1-201-689-8029 (outside the U.S.), Conference Title: TG Therapeutics.
|
Jul 14, 2021 at 12:30 PM EDT
|
Ladenburg Thalmann 2021 Healthcare Conference
|
Jun 22, 2021 at 10:00 AM EDT
|
Raymond James Human Health Innovation Conference
|
Jun 08, 2021 at 1:20 PM EDT
|
Goldman Sachs 42nd Annual Global Healthcare Conference
|
Jun 01, 2021 at 2:00 PM EDT
|
Jefferies Virtual Healthcare Conference
|
May 10, 2021 at 8:30 AM EDT
|
TG Therapeutics Q1 2021 Earnings Call and Business Update
Dial in phone numbers: 1-877-407-8029 (U.S.), 1-201-689-8029 (Ex-US)
|
Apr 28, 2021 at 9:00 AM EDT
|
B. Riley Securities’ Virtual Neuroscience Conference Webcast
|
Apr 16, 2021 at 8:30 AM EDT
|
ULTIMATE I & II Phase 3 Data Preview Call
Key Opinion Leader Participants:
View Presentation 1 MB
|
Mar 09, 2021 at 7:00 AM EST
|
H.C. Wainwright Global Life Sciences Conference
|
Mar 02, 2021 at 8:30 AM EST
|
TG Therapeutics Fourth Quarter and Year End 2020 Update Call
Attendees may also join via phone by dialing 1-877-407-8029 (U.S.), 1-201-689-8029 (outside the U.S.), Conference Title: TG Therapeutics Fourth Quarter and Year End 2020 Update Call
|
Feb 08, 2021 at 8:30 AM EST
|
TG Therapeutics UKONIQ (umbralisib) FDA Approval Call
In order to participate in the conference call, please call 1-877-407-8029 (U.S.) 1-201-689-8029 (outside the U.S.), Conference Title: TG Therapeutics
View Presentation 1.3 MB
|
Jan 20, 2021 at 10:00 AM EST
|
B. Riley Securities Oncology Investor Conference
|
Jan 12, 2021 at 2:00 PM EST
|
39th Annual J.P. Morgan Healthcare Conference
View Presentation 1.8 MB
|
Dec 10, 2020 at 8:30 AM EST
|
TG Therapeutics ULTIMATE I & II Call
|
Dec 01, 2020 at 10:05 AM EST
|
Evercore ISI 3rd Annual HealthCONx Conference
|
Nov 17, 2020 at 7:20 PM GMT
|
Jefferies Virtual London Conference
|
Nov 05, 2020 at 8:45 AM EST
|
TG Therapeutics ASH Abstract Release Call
Attendees may also join via phone by dialing 1-877-407-8029 (U.S.), 1-201-689-8029 (outside the U.S.), Conference Title: TG Therapeutics ASH Abstract Review Call.
|
Sep 16, 2020 at 10:40 AM EDT
|
Cantor Fitzgerald Global Healthcare Conference
|
Sep 14, 2020 at 1:30 PM EDT
|
H.C. Wainwright 22nd Annual Global Investment Conference
|
Aug 10, 2020 at 8:30 AM EDT
|
Second Quarter 2020 Earnings Results
|
Jun 18, 2020 at 3:40 PM EDT
|
Raymond James 2020 Human Health Innovation Conference
View Presentation 1.4 MB
|
Jun 11, 2020 at 4:40 PM EDT
|
Goldman Sachs 41st Annual Global Healthcare Conference
|
Jun 03, 2020 at 10:00 AM EDT
|
Jefferies 2020 Healthcare Conference
|
May 05, 2020 at 8:30 AM EDT
|
Update Conference Call & Webcast
CONFERENCE CALL INFORMATION: |
Mar 03, 2020 at 8:00 AM EST
|
Fourth Quarter 2019 Earnings Results
|
Jan 16, 2020 at 8:00 AM PST
|
38th Annual J.P. Morgan Healthcare Conference
View Presentation 2 MB
|
Dec 09, 2019 at 7:30 PM EST
|
TG THERAPEUTICS INVESTOR & ANALYST EVENT
View Presentation 586.5 KB
|
Nov 20, 2019 at 11:20 AM GMT
|
Jefferies London Healthcare Conference
|
Nov 12, 2019 at 8:30 AM EST
|
Third Quarter 2019 Earnings Results
|
Oct 28, 2019 at 8:30 AM EDT
|
TG Therapeutics Update Call
|
Oct 02, 2019 at 4:10 PM EDT
|
2019 Cantor Global Healthcare Conference
View Presentation 1.6 MB
|
Sep 24, 2019 at 11:00 AM EDT
|
Ladenburg Thalmann Healthcare Conference
|
Aug 09, 2019 at 8:30 AM EDT
|
Second Quarter 2019 Earnings Results
|
Jun 19, 2019 at 9:10 AM EDT
|
Raymond James Life Sciences and MedTech Conference
|
Jun 05, 2019 at 9:00 AM EDT
|
Jefferies 2019 Healthcare Conference
|
May 20, 2019
|
May 2019 Corporate Presentation
View Presentation 1.4 MB
|
May 10, 2019 at 8:00 AM EDT
|
First Quarter 2019 Earnings Results
|
Apr 09, 2019 at 4:50 PM EDT
|
18th Annual Needham Healthcare Conference
|
Apr 01, 2019 at 12:00 PM EDT
|
TG Therapeutics AACR 2019 Data Review Call
Participant / Guest (Toll-Free): 877-407-8029
View Presentation 1.3 MB
|
Mar 13, 2019 at 11:20 AM EDT
|
Cowen 39th Annual Health Care Conference
|
Feb 28, 2019 at 8:30 AM EST
|
TG Therapeutics Update Call
Participant / Guest (Toll-Free): 877-407-8029 |
Jan 10, 2019 at 1:00 PM EST
|
37th Annual J.P. Morgan Healthcare Conference
|
Dec 02, 2018 at 8:00 PM PST
|
TG Therapeutics December 2018 Investor & Analyst Event
The event will take place at the Marriott Gaslamp in San Diego California. This event will also be broadcast via conference call. To access the conference line, please call 1-877-407-8029 (U.S.), 1-201-689-8029 (outside the U.S.), and reference Conference Title: TG Therapeutics December 2018 Investor & Analyst Event.
View Presentation 5.7 MB
|
Nov 09, 2018 at 8:30 AM EST
|
Third Quarter 2018 Earnings Results
|
Oct 11, 2018 at 1:30 PM EDT
|
TG Therapeutics ECTRIMS Data Review Call
Teleconference Information:
View Presentation 1.7 MB
|
Oct 02, 2018 at 1:00 PM EDT
|
Ladenburg Thalmann 2018 Healthcare Conference
|
Oct 01, 2018 at 2:20 PM EDT
|
Cantor Fitzgerald Global Healthcare Conference
|
Sep 25, 2018 at 8:30 AM EDT
|
TG Therapeutics Update Call
Teleconference Information: |
Aug 07, 2018 at 4:30 PM EDT
|
Second Quarter 2018 Earnings Results
Teleconference Information: |
Jun 07, 2018 at 10:30 AM EDT
|
Jefferies 2018 Global Healthcare Conference
|
Jun 03, 2018 at 8:15 PM EDT
|
TG Therapeutics Analyst & Investor Event
Teleconference Information:
View Presentation 5.4 MB
|
May 08, 2018 at 8:30 AM EDT
|
First Quarter 2018 Earnings Results
|
Mar 28, 2018 at 4:00 PM EDT
|
Needham 17th Annual Healthcare Conference
|
Mar 12, 2018 at 1:30 PM EDT
|
Cowen 38th Annual Health Care Conference
|
Mar 08, 2018 at 8:30 AM EST
|
Fourth Quarter 2017 Earnings Results
|
Mar 06, 2018 at 2:50 PM EST
|
Raymond James & Associates' 39th Annual Institutional Investors Conference
|
Jan 11, 2018 at 7:30 AM PST
|
36th Annual J.P. Morgan Healthcare Conference
View Presentation 1.4 MB
|
Dec 10, 2017 at 8:15 PM EST
|
TG Therapeutics Investor & Analyst Event
This event will also be broadcast via conference call. To access the conference line, please call 1-877-407-8029 (U.S.), 1-201-689-8029 (outside the U.S.), and reference Conference Title: TG Therapeutics December 2017 Investor & Analyst Event.
View Presentation 7.6 MB
|
Nov 08, 2017 at 8:30 AM EST
|
Third Quarter 2017 Earnings Results
|
Nov 02, 2017 at 8:30 AM EDT
|
Post ECTRIMS-ACTRIMS Conference Call
To participate in the conference call please dial 877-407-8029
View Presentation 2.6 MB
|
Sep 26, 2017 at 2:30 PM EDT
|
Ladenburg Thalmann 2017 Healthcare Conference
|
Sep 25, 2017 at 1:50 PM EDT
|
Cantor Fitzgerald Global Healthcare Conference
|
Aug 09, 2017 at 8:30 AM EDT
|
Second Quarter 2017 Earnings Results
|
Jun 08, 2017 at 2:00 PM EDT
|
Jefferies 2017 Global Healthcare Conference
|
Jun 05, 2017 at 7:00 PM CDT
|
TG Therapeutics Analyst and Investor event June 2017
View Presentation 3.3 MB
|
May 05, 2017 at 8:30 AM EDT
|
First Quarter 2017 Earnings Results
|
Mar 21, 2017 at 3:20 PM EDT
|
27th Annual Oppenheimer Healthcare Conference
|
Mar 14, 2017 at 3:00 PM PDT
|
29th Annual ROTH Conference
|
Mar 10, 2017 at 8:30 AM EST
|
Fourth Quarter 2016 Earnings Results
|
Mar 06, 2017 at 8:30 AM EST
|
TG Therapeutics Phase 3 GENUINE Positive Topline Data Call
You may need to disable a pop-up blocker to access the webcast replay. |
Feb 13, 2017 at 9:00 AM EST
|
Biotechnology Innovation Organization 2017 BIO CEO & Investor Conference
|
Jan 12, 2017 at 10:30 AM PST
|
35th Annual J.P. Morgan Healthcare Conference
View Presentation 3.3 MB
|
Dec 05, 2016 at 8:00 PM PST
|
TG Therapeutics December Analyst & Investor Event
View Presentation 4.3 MB
|
Nov 07, 2016 at 8:30 AM EST
|
Third Quarter 2016 Earnings Results
|
Oct 13, 2016 at 8:30 AM EDT
|
Update on the GENUINE Phase 3 Trial
|
Sep 27, 2016 at 11:30 AM EDT
|
Ladenburg Thalmann 2016 Healthcare Conference
|
Aug 08, 2016 at 8:30 AM EDT
|
Second Quarter 2016 Earnings Results
|
Jun 10, 2016 at 10:00 AM EDT
|
Jefferies 2016 Healthcare Conference
|
Jun 06, 2016 at 7:10 PM CDT
|
TG Therapeutics 2016 Investor & Analyst Event
View Presentation 2.7 MB
|
May 10, 2016 at 4:30 PM EDT
|
TG Therapeutics First Quarter 2016 Financial Results and Business Update
|
Mar 15, 2016 at 3:30 PM PDT
|
28th Annual ROTH Conference
|
Mar 09, 2016 at 9:20 AM EST
|
Cowen and Company 36th Annual Health Care Conference
|
Mar 08, 2016 at 11:35 AM EST
|
Raymond James & Associates' 37th Annual Institutional Investors Conference
|
Mar 07, 2016 at 4:30 PM EST
|
TG Therapeutics Fourth Quarter 2015 Financial Results and Business Update
|
Feb 08, 2016 at 1:00 PM EST
|
18th Annual BIO CEO & Investor Conference
|
Jan 14, 2016 at 9:00 AM PST
|
34th Annual J.P. Morgan Healthcare Conference
|
Dec 07, 2015 at 8:00 PM EST
|
TG Therapeutics 2015 Investor & Analyst Event
TG Therapeutics will also host a reception on Monday, December 7th, 2015 beginning at 7:45pm ET, with featured presentations beginning promptly at 8:00pm ET. The event will take place at the Hyatt Regency Orlando in the Bayhill 17/18 Room. This event will be webcast live and will be available on the Events page, located within the Investors & Media section of the Company's website at www.tgtherapeutics.com,as well as archived for future review. This event will also be broadcast via conference call. In order to access the conference line, please call 1-877-407-8029 (U.S.), 1-201-689-8029 (outside the U.S.), and reference Conference Title: TG Therapeutics 2015 Investor & Analyst Event.
View Presentation 3.6 MB
|
Nov 09, 2015 at 8:30 AM EST
|
TG Therapeutics Third Quarter 2015 Financial
|
Sep 29, 2015 at 9:00 AM EDT
|
Ladenburg Thalmann 2015 Healthcare Conference
|
Sep 09, 2015 at 3:00 PM EDT
|
Rodman & Renshaw Annual Global Investment Conference
|
Aug 10, 2015 at 8:30 AM EDT
|
TG Therapeutics Second Quarter 2015 Financial
|
Jun 03, 2015 at 4:30 PM EDT
|
Jefferies 2015 Healthcare Conference
|
May 31, 2015 at 6:15 PM CDT
|
TG THERAPEUTICS' 2015 ANALYST & INVESTOR EVENT
SHERATON CHICAGO HOTEL & TOWERS
View Presentation 2.5 MB
|
May 06, 2015 at 8:40 AM EDT
|
Deutsche Bank 40th Annual Health Care Conference
|
May 05, 2015 at 8:00 AM EDT
|
TG Therapeutics First Quarter 2015 Financial
|
Apr 20, 2015
|
106th Annual Meeting of the American Association for Cancer Research (AACR)
|
Mar 12, 2015 at 8:30 AM EDT
|
TG Therapeutics Fourth Quarter 2014 Financial
|
Mar 09, 2015 at 3:00 PM PDT
|
27th Annual ROTH Conference
|
Mar 04, 2015 at 10:40 AM EST
|
Cowen and Company 35th Annual Health Care Conference
|
Feb 09, 2015 at 2:30 PM EST
|
17th Annual BIO CEO & Investor Conference
|
Jan 15, 2015 at 8:30 AM PST
|
33rd Annual J.P. Morgan Healthcare Conference
View Presentation 2.6 MB
|
Dec 09, 2014 at 8:30 AM PST
|
Ublituximab, A Novel Glycoengineered Anti-CD20 Monoclonal Antibody (mAb), In Combination With TGR-1202, A Next Generation Once Daily PI3k delta Inhibitor, Demonstrates Activity In Heavily Pre-Treated And High-Risk CLL And B-Cell Lymphoma
Oral Session: 801
View Presentation 934 KB
|
Dec 08, 2014 at 10:45 PM EST
|
TG Therapeutics' 2014 Analyst & Investor Event
|
Dec 01, 2014 at 2:50 PM EST
|
2014 Deutsche Bank BioFEST
|
Nov 11, 2014 at 8:30 AM EST
|
TG Therapeutics Third Quarter 2014 Financial
|
Sep 09, 2014 at 1:15 PM EDT
|
16th Annual Rodman & Renshaw Global Investment Conference
|
Jul 22, 2014 at 8:30 AM EDT
|
TG Therapeutics Second Quarter 2014 Financial Results
|
Jun 24, 2014 at 4:30 PM EDT
|
JMP Securities Healthcare Conference
|
Jun 17, 2014 at 2:55 PM EDT
|
2014 Wells Fargo Healthcare Conference
|
May 13, 2014 at 8:30 AM EDT
|
TG Therapeutics First Quarter 2014 Financial
|
May 08, 2014 at 12:50 PM EDT
|
39th Annual Deutsche Bank Healthcare Conference
View Presentation
1.4 MB
|
Mar 11, 2014 at 11:30 AM PDT
|
26th Annual ROTH Conference
|
Mar 06, 2014 at 8:30 AM EST
|
TG Therapeutics Fourth Quarter 2013 and Year-End 2013 Financial Results and Business Update
|
Feb 10, 2014 at 3:00 PM EST
|
16th Annual BIO CEO & Investor Conference
|
Jan 16, 2014 at 1:00 PM PST
|
32nd Annual J.P. Morgan Healthcare Conference
View Presentation 1.1 MB
|